Japan· JP-6313400E1025
乾燥組織培養不活化狂犬病ワクチン
A medicinal product containing 乾燥組織培養不活化狂犬病ワクチン, registered in Japan by オーファンパシフィック, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- 乾燥組織培養不活化狂犬病ワクチン
- Manufacturer
- オーファンパシフィック
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
乾燥組織培養不活化狂犬病ワクチン in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRabies vaccine powder and solvent for solution for injection 1ml vialsA A H Pharmaceuticals Ltd
- GermanyVerorabSanofi Winthrop Industrie
- FinlandRabies-ImovaxSanofi Pasteur Europe
- PolandRabipurBavarian Nordic A/S
- NorwayVerorabSanofi Pasteur
- IrelandVerorab, powder and solvent for suspension for injection. Rabies vaccine, inactivated.Sanofi Winthrop Industrie
- CanadaRABAVERTBAVARIAN NORDIC AS
- FranceRABIPUR, poudre et solvant pour solution injectable en seringue préremplie. Vaccin rabique (inactivé)BAVARIAN NORDIC (DANEMARK)
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Verorab
- Belgium · Verorab
- Bulgaria · Верораб
- Czechia · Verorab
- Germany · Verorab
- Denmark · Verorab
- Estonia · Verorab
- Spain · Verorab
- Finland · Verorab
- France · Vaccin Rabique, Verorab
- United Kingdom (Northern Ireland) · Verorab
- Hungary · Verorab
- Ireland · Verorab
- Italy · Verorab
- Lithuania · Verorab
- Latvia · Verorab
- Netherlands · Verorab
- Norway · Verorab
- Poland · Verorab
- Romania · Verorab
- Sweden · Verorab
- Slovakia · Verorab
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4b1073cf-7b0b-4f71-ac0f-2299a3651782 GET /v1/drugs/4b1073cf-7b0b-4f71-ac0f-2299a3651782?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１瓶（溶解液付）",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6313400E1025",
"category": "注射薬",
"price_yen": 12087,
"generic_name": "乾燥組織培養不活化狂犬病ワクチン",
"product_name_jp": null,
"therapeutic_class": "6313",
"transitional_expiry": null
}See everything about 乾燥組織培養不活化狂犬病ワクチン.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.